BeOne Medicines (ONC) Enterprise Value (2015 - 2026)
BeOne Medicines (ONC) reported Enterprise Value of -$4.8 billion for Q1 2026, down 90.42% year-over-year from -$50.0 billion in Q1 2025, and down 5.37% on a QoQ basis from -$4.5 billion in Q4 2025.
BeOne Medicines (ONC) has 12 years of Enterprise Value data on file, last reported at -$4.8 billion in Q1 2026.
- Quarterly Enterprise Value fell 90.42% year-over-year to -$4.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.8 billion (down 90.42% YoY) and the FY2025 annual result came in at -$4.5 billion, down 73.08% from the prior year.
- Enterprise Value eased to -$4.8 billion in Q1 2026 per ONC's latest filing, from -$4.5 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$872.2 million in Q3 2022 and bottomed at -$5.7 billion in Q2 2022.
- The 5-year median for Enterprise Value is -$3.2 billion (2023), against an average of -$3.3 billion.
- The widest annual swing landed in 2022, when Enterprise Value soared 77.73%; it then tumbled 263.95% in 2023.
- Tracing ONC's Enterprise Value over 5 years: stood at -$4.5 billion in 2022, then climbed by 30.0% to -$3.2 billion in 2023, then increased by 17.23% to -$2.6 billion in 2024, then plunged by 73.08% to -$4.5 billion in 2025, then decreased by 5.37% to -$4.8 billion in 2026.
- Per Business Quant, the three latest ONC Enterprise Value figures stand at -$4.8 billion (Q1 2026), -$4.5 billion (Q4 2025), and -$4.0 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -8.75 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -3.01 Bn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | -4.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.79 Bn |
| Dec 31, 2025 | -4.55 Bn |
| Sep 30, 2025 | -4.04 Bn |
| Jun 30, 2025 | -2.76 Bn |
| Mar 31, 2025 | -2.52 Bn |
| Dec 31, 2024 | -2.63 Bn |
| Sep 30, 2024 | -2.70 Bn |
| Jun 30, 2024 | -2.59 Bn |
| Mar 31, 2024 | -2.79 Bn |
| Dec 31, 2023 | -3.17 Bn |
| Sep 30, 2023 | -3.17 Bn |
| Jun 30, 2023 | -3.52 Bn |
| Mar 31, 2023 | -3.83 Bn |
| Dec 31, 2022 | -4.53 Bn |
| Sep 30, 2022 | -872.19 Mn |
| Jun 30, 2022 | -5.70 Bn |
| Mar 31, 2022 | -1.90 Bn |
| Dec 31, 2021 | -2.24 Bn |
| Sep 30, 2021 | -3.92 Bn |
| Jun 30, 2021 | -4.38 Bn |
| Mar 31, 2021 | -2.91 Bn |
| Dec 31, 2020 | -4.65 Bn |
| Sep 30, 2020 | -4.70 Bn |
| Jun 30, 2020 | -1.80 Bn |
| Mar 31, 2020 | -1.40 Bn |
| Dec 31, 2019 | -966.59 Mn |
| Sep 30, 2019 | -374.28 Mn |
| Jun 30, 2019 | -615.98 Mn |
| Mar 31, 2019 | -850.16 Mn |
| Dec 31, 2018 | -1.07 Bn |
| Sep 30, 2018 | -1.39 Bn |
| Jun 30, 2018 | -1.36 Bn |
| Mar 31, 2018 | -976.50 Mn |
| Dec 31, 2017 | -823.09 Mn |
| Sep 30, 2017 | -743.09 Mn |
| Jun 30, 2017 | -393.01 Mn |
| Mar 31, 2017 | -327.48 Mn |
| Dec 31, 2016 | -368.17 Mn |
| Sep 30, 2016 | -203.62 Mn |
| Jun 30, 2016 | -226.62 Mn |
| Mar 31, 2016 | -247.23 Mn |
| Dec 31, 2015 | -100.49 Mn |
| Sep 30, 2015 | -27.45 Mn |
| Jun 30, 2015 | -25.16 Mn |
| Mar 31, 2015 | -13.37 Mn |